Evaluation of Potential Antigen-specific Host Biomarkers in QuantiFERON Supernatants as Candidates for the Diagnosis of Ocular Tuberculosis

被引:3
|
作者
Makhoba, Nonjabulo S. [1 ,2 ,3 ]
Smit, Derrick P. [4 ]
Walzl, Gerhard [1 ,2 ,3 ]
Chegou, Novel N. [1 ,2 ,3 ]
机构
[1] Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa
[2] Stellenbosch Univ, South African Med Res Council, Ctr TB Res, Cape Town, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Cape Town, South Africa
[4] Stellenbosch Univ, Fac Med & Hlth Sci, Div Ophthalmol, POB 241, Cape Town, South Africa
基金
新加坡国家研究基金会;
关键词
Host biomarkers; quantiferon supernatants; diagnosis; ocular tuberculosis; candidate biosignatures; MYCOBACTERIUM-TUBERCULOSIS; CYTOKINE; TB;
D O I
10.1080/09273948.2020.1763404
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate potential host biomarkers detectable in QuantiFERON supernatants as diagnostic candidates for ocular tuberculosis (OTB). Methods We investigated 47 host markers in QuantiFERON supernatants from 92 individuals with uveitis using the Luminex platform. We evaluated the potential of individual and combined biomarkers to distinguish between patients with possible, probable, and no OTB. Results Differences were observed in median concentrations of several biomarkers including IL-13, IFN-gamma, IFN-alpha 2, and IL-1 beta, in individuals with OTB versus no OTB regardless of HIV status. Individuals with probable and possible OTB only differed regarding GM-CSF. We identified a four-marker biosignature (CD40 L, IL-33, IFN-gamma, and SAP) which diagnosed OTB with an area under the ROC curve of 0.80, sensitivity = 56.3% and specificity = 90.0%. Conclusion This represents the first attempt at screening QuantiFERON supernatants for biomarkers to diagnose OTB. We identified candidate biosignatures which may aid in diagnosing OTB in both HIV positive and negative patients.
引用
收藏
页码:1480 / 1488
页数:9
相关论文
共 49 条
  • [41] Adoptive therapy with redirected MHC class I-restricted antigen-specific regulatory T cells is a potential novel cellular therapy for graft-versus-host disease
    Uttenthal, B. J.
    Carpenter, B.
    Ghorashian, S.
    Wright, G. P.
    Flutter, B.
    Xue, S.
    Chakraverty, R.
    Morris, E. C.
    HUMAN GENE THERAPY, 2011, 22 (10) : A73 - A73
  • [42] Adoptive therapy with redirected MHC class I-restricted antigen-specific regulatory T cells is a potential novel cellular therapy for graft-versus-host disease
    Uttenthal, B. J.
    Carpenter, B.
    Ghorashian, S.
    Wright, G. P.
    Flutter, B.
    Xue, S. A.
    Chakraverty, R.
    Morris, E. C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 8 - 8
  • [43] Evaluation of Antigen Detection Test (Chromatographic Immunoassay): Potential to Replace the Antibody Assay Using Purified 45-kDa Protein for Rapid Diagnosis of Tuberculosis
    Tasbiti, Alireza Hadizadeh
    Bahrmand, Ahmadreza
    Shokrgozar, Mohammad Ali
    Ghanaie, Mostafa
    Fateh, Abolfazl
    Karimi, Ali
    Yari, Shamsi
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (01) : 70 - 76
  • [44] Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT®.TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China
    Yang, Chi
    Zhang, Shaojun
    Yao, Lan
    Fan, Lin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (05) : 1815 - 1825
  • [45] Efficiency of RD-1 antigen-specific interferon-γ release assays (IGRAs) blood-based tests for the diagnosis of Mycobacterium tuberculosis infection in Pott's disease at a tertiary care hospital
    Kumar, M.
    Kumar, R.
    Nag, V. L.
    Krishnani, N.
    Singh, U.
    Dhole, T. N.
    Maurya, A. K.
    Babu, S. G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S27 - S28
  • [46] CD38 Expression by Antigen-Specific CD4 T Cells Is Significantly Restored 5 Months After Treatment Initiation Independently of Sputum Bacterial Load at the Time of Tuberculosis Diagnosis
    Hiza, Hellen
    Hella, Jerry
    Arbues, Ainhoa
    Sasamalo, Mohamed
    Misana, Veronica
    Fellay, Jacques
    Gagneux, Sebastien
    Reither, Klaus
    Portevin, Damien
    FRONTIERS IN MEDICINE, 2022, 9
  • [47] Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA
    Xue, Ning
    Lin, Jian-Hua
    Xing, Shan
    Liu, Dan
    Li, Shi-Bing
    Lai, Yan-Zhen
    Wang, Xue-Ping
    Mao, Min-Jie
    Zhong, Dian
    Zeng, Mu-Sheng
    Liu, Wan-Li
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 378 - 390
  • [48] Development of an MHC-peptide array for the detection and isolation of antigen-specific T-cells: Applications in bone marrow transplantation for evaluation of T-cell reconstitution, and detection of host reactive and tumor-reactive T-cells
    Kraft, DL
    Soen, Y
    Chen, DS
    Weissman, IL
    Brown, PO
    Davis, MM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 24 - 24
  • [49] Modeling and Immune Monitoring of Human Adaptive T and B Antigen-Specific Responses in Humanized Mice Upon Immunizations With Lentivirus-Induced Dendritic Cells: Potential Application for Functional Evaluation of Genetically Modified Human Hematopoietic Stem Cells
    Salguero, Gustavo
    Daenthasanmak, Anusara
    Raykova, Ana
    Muenz, Christian
    Guzman, Carlos A.
    Riese, Peggy
    Figueiredo, Constanca
    Witte, Torsten
    Ganser, Arnold
    Stripecke, Renata
    MOLECULAR THERAPY, 2014, 22 : S179 - S179